Correlation Between Editas Medicine and Denali Therapeutics
Can any of the company-specific risk be diversified away by investing in both Editas Medicine and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Editas Medicine and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Editas Medicine and Denali Therapeutics, you can compare the effects of market volatilities on Editas Medicine and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Editas Medicine with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Editas Medicine and Denali Therapeutics.
Diversification Opportunities for Editas Medicine and Denali Therapeutics
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Editas and Denali is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Editas Medicine and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Editas Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Editas Medicine are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Editas Medicine i.e., Editas Medicine and Denali Therapeutics go up and down completely randomly.
Pair Corralation between Editas Medicine and Denali Therapeutics
Given the investment horizon of 90 days Editas Medicine is expected to under-perform the Denali Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Editas Medicine is 1.08 times less risky than Denali Therapeutics. The stock trades about -0.55 of its potential returns per unit of risk. The Denali Therapeutics is currently generating about -0.39 of returns per unit of risk over similar time horizon. If you would invest 1,987 in Denali Therapeutics on January 25, 2024 and sell it today you would lose (431.00) from holding Denali Therapeutics or give up 21.69% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Editas Medicine vs. Denali Therapeutics
Performance |
Timeline |
Editas Medicine |
Denali Therapeutics |
Editas Medicine and Denali Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Editas Medicine and Denali Therapeutics
The main advantage of trading using opposite Editas Medicine and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Editas Medicine position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.Editas Medicine vs. Beam TherapeuticsInc | Editas Medicine vs. Crispr Therapeutics AG | Editas Medicine vs. Caribou Biosciences | Editas Medicine vs. Verve Therapeutics |
Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular TherapeuticsInc | Denali Therapeutics vs. Ascendis Pharma AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |